[HTML][HTML] Mechanisms of chronic cardiac allograft rejection

JP Costello, T Mohanakumar… - Texas Heart Institute …, 2013 - ncbi.nlm.nih.gov
Chronic rejection in the form of cardiac allograft vasculopathy is one of the major factors that
affects long-term graft and patient survival after heart transplantation. Whereas multiple …

Multimodality noninvasive imaging in the monitoring of pediatric heart transplantation

SJ Kindel, HH Hsu, T Hussain, JN Johnson… - Journal of the American …, 2017 - Elsevier
Highlights•Multimodality cardiac imaging plays a key role in the care of pediatric patients
after heart transplantation.•Alterations in diastolic functional indices become evident before …

Improved detection of cardiac allograft vasculopathy: a multi-institutional analysis of functional parameters in pediatric heart transplant recipients

SJ Kindel, YM Law, C Chin, M Burch, JK Kirklin… - Journal of the American …, 2015 - jacc.org
Background: Recent guidelines recommend assessment of systolic function and filling
pressures to augment angiographic grading of cardiac allograft vasculopathy (CAV); …

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

D Kobayashi, W Du, TJ L'ecuyer - Pediatric transplantation, 2013 - Wiley Online Library
CAV remains a leading cause of late graft loss and mortality among survivors of pediatric
heart transplantation. We sought to define the incidence of CAV and identify its predictors in …

[HTML][HTML] Multi-modal imaging of the pediatric heart transplant recipient

JH Soslow, MM Samyn - Translational pediatrics, 2019 - ncbi.nlm.nih.gov
The assessment of pediatric patients after orthotropic heart transplantation (OHT) relies
heavily on non-invasive imaging. Because of the potential risks associated with cardiac …

Safety of optical coherence tomography in pediatric heart transplant patients

SM Ulrich, A Lehner, J Birnbaum, S Heckel… - International journal of …, 2017 - Elsevier
Background Cardiac allograft vasculopathy (CAV) is a crucial problem after heart
transplantation, in adults as well as in children. CAV is the main risk factor for a reduced long …

Late graft dysfunction after pediatric heart transplantation is associated with fibrosis and microvasculopathy by automated, digital whole-slide analysis

B Feingold, J Picarsic, A Lesniak, BA Popp… - The Journal of Heart and …, 2017 - Elsevier
Background Histopathologic features of late graft dysfunction (LGD) in endomyocardial
biopsies (EMBs) after pediatric heart transplantation (HT) have been incompletely described …

[PDF][PDF] Cardiac allograft vasculopathy: microvascular arteriolar capillaries ('capioles”) and survival

CA Labarrere, BR Jaeger, GS Kassab - Front Biosci, 2017 - article.imrpress.com
Cardiac allograft vasculopathy (CAV) is a serious complication of heart transplantation in
adults and children. Risk factors include human leukocyte antigen mismatches, number and …

Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group

JW Rossano, JL Jefferies, E Pahl, DC Naftel… - The Journal of Heart and …, 2017 - Elsevier
Background Proliferation signal inhibitors, such as sirolimus, are increasingly used in solid-
organ transplantation. However, limited data exist on sirolimus-treated pediatric patients. We …

Interaction of older donor age and survival after weight-matched pediatric heart transplantation

TC Westbrook, DLS Morales, MS Khan, R Bryant… - The Journal of Heart and …, 2017 - Elsevier
Background Donors are matched for weight in pediatric heart transplantation (PHT), yet age
differences are not considered in this decision. In this study we attempt to identify the effect …